Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option: This Viewpoint suggests that clinicians prescribe
Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option: This Viewpoint suggests that clinicians prescribe human insulin products as a more-affordable option over insulin analogues and explains dosing options. Kasia J. Lipska. Irl B. Hirsch. Matthew C. Riddle. JAMA.
Source: jamanetwork.com
FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey,
FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The FDA has approved an insulin glargine injection (marketed as Basaglar) for treating type 1 (adult and pediatric patients) and … NEJM Journal Watch.
Source: jwatch.org
RSS feed